Editor's Note: Gary B. Smith's column runs exclusively on RealMoney.com; this is a special free look at his column. For a free trial subscription to RealMoney.com, click here. This article was published Nov. 20 on RealMoney.

In the "tying up loose ends" department, loyal readers will recall that I

wrote about

Indigo

software a couple of years back. I will admit I was skeptical, but instead of taking a position, I merely asked readers for their feedback. Boy, did I get an earful...

Image placeholder title

In any event, alert reader Neil L. sent me a note with the latest. Check out

this link -- and buyer beware, I guess.

Today, charts on a recent

Arne Alsin pick,

Dillard's

(DDS) - Get Report

, and along with that, the

Nasdaq

,

PacifiCare Health

(PHSY)

,

Texas Instruments

(TXN) - Get Report

,

Enesco

(ENC)

,

Amdocs

(DOX) - Get Report

and

FedEx

(FDX) - Get Report

.

And that's a wrap from Television City, where I'm betting that if the

Friends

cast doesn't re-up, you won't hear a peep from any of them ever again.

Gary B. Smith is a freelance writer who trades for his own account from his Maryland home using technical analysis. At time of publication, he held no positions in any securities mentioned in this column, although holdings can change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Smith writes a daily technical analysis column for RealMoney.com and produces a daily premium product for TheStreet.com called

The Chartman's Top Stocks. While he cannot provide investment advice or recommendations, he invites you to send your feedback to

Gary B. Smith.